Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Developmental disabilities (DDs) are conditions characterized by physical, cognitive, psychological, sensory, adaptive, and/or communication impairments manifested during development. Approximately 17% of individuals in the United States 18 years and younger have a DD, and for most children the cause of their condition is unknown. Of particular interest are the autism spectrum disorders (ASDs), characterized by unusual social, communication, and behavioral development. Previously autism was thought to be a rare condition, but the number of children receiving services for an ASD has increased dramatically in the last decade. Concerns about increases in DDs, particularly ASDs, their causes, and the high costs of intervention have highlighted the need for systematic public health monitoring. Service provider data, such as annual reporting of special education services or of state DD programs, do not provide a complete estimate of the rates for DDs, including ASDs. Unlike genetic metabolic disorders or congenital hearing loss (HL) for which newborn screening programs can provide accurate prevalence rates, there are currently no genetic or biologic markers for the ASDs to enable consistent and early identification of affected children. Centers for Disease Control and Prevention's (CDC) Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP) is a model for population monitoring of ASDs/DDs that has been implemented in other states. This article discusses the role of ASD/DD tracking in public health, as well as the challenges of ASD/DD tracking, including case definition and identification, associated conditions, linkages, and data access. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248 · cited 4×
“…causes of DDs, ongoing public health monitoring of DD prevalence and associated characteristics can provide an important base of information to identify high-risk groups and conditions that warrant further research into risk and causal factors [Yeargin-Allsopp, 2002; Yeargin-Allsopp et al., 2003].”
BackgroundMethodInfluentialSelf-citationPervasive Developmental Disorders in preschool children
Chakrabarti, S. (2001) · JAMA · doi:10.1001/jama.285.24.3093 · Cited by 1,132 · cited 2×
“the full spectrum of the autism disorders [Chakrabarti and Fombonne, 2001].”
BackgroundThe epidemiology of autism: a review
FOMBONNE, E. (1999) · Psychological Medicine · doi:10.1017/s0033291799008508 · Cited by 981 · cited 2×
“…information about comorbid conditions such as MR, epilepsy, fragile X, and tuberous sclerosis, among others, and has documented related sociodemographic factors such as gender predilection, ethnic distribution and age at diagnosis [Fombonne, 1999; Gillberg and Wing, 1999; Cook et al., 2003].”
BackgroundInfluentialGenetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
FMR1 and the fragile X syndrome: Human genome epidemiology review
Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · cited 2×
“Substantial advances in genetics have identified the genetic basis of many disorders that cause developmental problems [Flint and Wilkie, 1996], such as fragile X [Crawford et al., 2001], Prader-Willi and Angelman [Christian et al.”
BackgroundDiagnosis in Autism: A Survey of Over 1200 Patients in the UK
Howlin, P., & Moore, A. (1997) · Autism · doi:10.1177/1362361397012003 · Cited by 462
SIEGEL, B., PLINER, C., ESCHLER, J., & ELLIOTT, G. R. (1988) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-198808000-00004 · Cited by 132
Cited by
Levy, S. E., Giarelli, E., Lee, L.-C., Schieve, L. A., Kirby, R. S., Cunniff, C., Nicholas, J., Reaven, J., & Rice, C. E. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5d03b · Cited by 504
Self-citationWindham, G. C., Zhang, L., Gunier, R., Croen, L. A., & Grether, J. K. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9120 · Cited by 424
“Coordinated by the Centers for Disease Control and Prevention (CDC), these programs have been organized into Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) and Autism and Developmental Disorders Monitoring (Rice et al. 2004; Yeargin-Allsopp et al. 2003).”
MethodAnnual research review: re-thinking the classification of autism spectrum disorders
Lord, C., & Jones, R. M. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02547.x · Cited by 290
Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002.
Gallagher, C. M., & Goodman, M. S. (2010) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2010.519317 · Cited by 72
“Because greater hepatitis B surface antigen prevalence was found among pregnant Asian women in the United States compared to other race/ethnic groups (Euler et al. 2003), it is plausible that Asian neonates are more likely to have been vaccinated at birth; however, in this U.S. probability sample, none of the male chi…”
BackgroundInfluentialRetractedPrevalence of pervasive developmental disorders in two Canadian provinces
Ouellette‐Kuntz, H., Coo, H., Yu, C. T., Chudley, A. E., Noonan, A., Breitenbach, M., Ramji, N., Prosick, T., Bedard, A., & Holden, J. J. A. (2006) · Journal of Policy and Practice in Intellectual Disabilities · doi:10.1111/j.1741-1130.2006.00076.x · Cited by 39
Metadata
- Authors
- Rice, C., Schendel, D., Cunniff, C., & Doernberg, N.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2004-01-14
- Volume
- 125C
- Issue
- 1
- Pages
- 22-27
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2025488959
- Cited by
- 33
- References
- 7
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.